Dona Ferentes
Pengurus pengatur
- Joined
- 11 January 2016
- Posts
- 16,521
- Reactions
- 22,534
so do I @Faramir . The side effects will likely not be understood for a while... but it's 2023 and many expect magic bullets. They can always sue someone later on.i believe these drugs are too risky to take. Unfortunately people want quick fixes and they don’t care if they lose muscle weight instead fat weight.
Roger Ramjet, he's our man,
Hero of our nation.
For his adventures, just be sure
To stay tuned to this station.
When Ramjet takes a Proton Pill,
The crooks begin to worry.
They can't escape their awful fate
From Proton's mighty fury
Don't know much about humans, but the drug Ertugliflozin has been an absolute game changer in equine hyperinsulinemia.GLP-1 agonists: Diabetes drugs and weight loss
Are there any type 2 diabetes drugs that can help people lose weight and lower their blood sugar? Are there side effects?
.
There's a class of type 2 diabetes drugs that not only improves blood sugar control but may also lead to weight loss. This class of drugs is commonly called glucagon-like peptide 1 (GLP-1) agonists.
Weight loss can vary depending on which GLP-1 drug you use and your dose. Studies have found that all GLP-1 drugs can lead to weight loss of about 10.5 to 15.8 pounds (4.8 to 7.2 kilograms, or kg) when using liraglutide. Studies found people using semaglutide and making lifestyle changes lost about 33.7 pounds (15.3 kilograms) versus 5.7 pounds (2.6 kilograms) in those who didn't use the drug.
Diabetes drugs in the GLP-1 agonists class are generally taken by a shot (injection) given daily or weekly and include:
These drugs mimic the action of a hormone called glucagon-like peptide 1. When blood sugar levels start to rise after someone eats, these drugs stimulate the body to produce more insulin. The extra insulin helps lower blood sugar levels.
- Dulaglutide (Trulicity) (weekly)
- Exenatide extended release (Bydureon bcise) (weekly)
- Exenatide (Byetta) (twice daily)
- Semaglutide (Ozempic) (weekly)
- Liraglutide (Victoza, Saxenda) (daily)
- Lixisenatide (Adlyxin) (daily)
- Semaglutide (Rybelsus) (taken by mouth once daily)
Lower blood sugar levels are helpful for controlling type 2 diabetes. But it's not clear how the GLP-1 drugs lead to weight loss. Doctors do know that GLP-1s appear to help curb hunger. These drugs also slow the movement of food from the stomach into the small intestine. As a result, you may feel full faster and longer, so you eat less.
Along with helping to control blood sugar and boost weight loss, GLP-1s and SGLT-2 inhibitors seem to have other major benefits. Research has found that some drugs in these groups may lower the risk of heart disease, such as heart failure, stroke and kidney disease. People taking these drugs have seen their blood pressure and cholesterol levels improve. But it's not clear whether these benefits are from the drug or the weight loss.
The downside to GLP-1 drugs is that all but one has to be taken by a shot. And, like any drug, there is a risk of side effects, some serious. More common side effects often improve as you continue to take the drug for a while.
Some of the more common side effects include:
Low blood sugar levels (hypoglycemia) are a more serious risk linked to the GLP-1 class of drugs. But the risk of low blood sugar levels often only goes up if you're also taking another drug known to lower blood sugar at the same time, such as sulfonylureas or insulin.
- Nausea
- Vomiting
- Diarrhea
GLP-1 class of drugs isn't recommended if you have a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia. Lab studies have linked these drugs with thyroid tumors in rats. But until more long-term studies are done, the risk to humans isn't known. They're also not recommended if you've had pancreatitis. The drugs already discussed are indicated in people living with type 2 diabetes. There is also a drug that has a higher dose of liraglutide (Saxenda) that's approved for the treatment of obesity in people who don't have diabetes.
thanks for sharing @So_Cynical . Early days , but have you noticed any other changes, such as dietary preferences or a changed intake of alcohol? sleep patterns? exercise?.Results for me - lost 13kg or 11% of my starting weight without any additional exercise or dieting - super responder, Semaglutide is just a super easy way (idiot proof) to lose weight for most people.
There is a lot of online discussion going on about semaglutide and the other similar drugs, many different experiences from the different groups of people using so yep very early days, for me i have come to realise that im one of the lucky ones that responds very very well to the drug at the low starting dose of 0.25thanks for sharing @So_Cynical . Early days , but have you noticed any other changes, such as dietary preferences or a changed intake of alcohol? sleep patterns? exercise?
I hope VGS have some stake in Novo Nordisk
Its not Bex - Bex was 42% aspirin and 42% phenacetin plus caffeine. https://en.wikipedia.org/wiki/Bex_(compound_analgesic)am very much convinced that it is our modern day Bex. (Anyone remember Bex?)
Knowing the way obesity works, I think many miracle drug takers will see that as an opportunity to gorge on even more sodas and fake food burgersthis was posted elsewhere today (Buy the dip @eskys )and i think it can go here as well.
.
.
ResMed: Obesity Drugs
ResMed (ASX: RMD) shares are around down around 30% since August amid growing concerns about how obesity drugs may disrupt the sleep apnea market.
The latest note from Jarden notes that "following our discussions with key US sleep stakeholders, there is currently no sign of the impact of GLP-1 drugs on sleep lab referrals, diagnosis rates, CPAP setups and mask replacement." But there is an expectation that "there will be an impact due to the staggering increase in awareness and demand for these drugs and the role of weight loss in reducing OSA severity."
The broker cut its share price target by 16% to $30.33 but retained an Overweight rating.
View attachment 163840
Resmed 12-month price chart (Source: Market Index)
There's an expectation that weight loss drugs like Ozempic will pose a threat to several industries spanning from fast food restaurants to cigarette makers. Walmart's CEO John Furner said its already seeing an impact of the drugs on food demand, stating "we definitely do see a slight change compared to the total population, we do see a slight pullback in overall basket.".
.
.
will highlight the last para. So, if they can attribute a link there in food sales, how easy will it be to see the drop off in XXXXL clothing sales and other paraphernalia that has recently been developed .
and a million othersHeavy duty furniture - Extra Large Living
Looking for some sturdy furniture that won't cost you a fortune? We have compiled a list of our most popular reviews so you can find...www.extralargeliving.com
Knowing the way obesity works, I think many miracle drug takers will see that as an opportunity to gorge on even more sodas and fake food burgers
Another study recently about kidney failure, Novo Nordisk have stopped the trail early due to the overwhelming weight of evidence showing that Semaglutide massively reduces the risk of kidney failure.And a researchers' paradise, going forward
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?